The global downstream processing market size is expected to reach USD 49.9 billion by 2027, expanding at a CAGR of 13.1%, according to a new report by Grand View Research, Inc. The growing demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology propels market growth.
The
downstream processing technology is being increasingly used in both laboratory
and industrial-scale bioprocessing applications owing to a growing demand for
biologics, which is anticipated to boost industry growth. In addition, the
advantages offered by the use of single-use bioprocessing equipment are also
expected to drive the growth of the market.
According
to a recent study conducted by GE Healthcare, the application of single-use
bioprocessing equipment reduced nearly 55% of the total impact across five
impact categories. These categories included natural resources, ecosystem
quality, climate change, human health, and freshwater withdrawal. This study
was associated with the development of monoclonal antibodies.
The
growth of the market is considerably restrained by high cost of the procedure
and a lack of skilled professionals. The industry players are keen on adopting
outsourcing activities and contract manufacturing organizations are helping
pharma manufacturers to optimize their downstream processing workflow and
minimize their initial capital investment costs. The industry players are also
increasing their R&D investments to expand their product pipeline and
strengthen their position in the market.
Full Research Report On Downstream Processing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/downstream-processing-market
Downstream
Processing Market Report Highlights
- Biopharmaceuticals is a
major growth prospect and many healthcare entities have estimated that the
innovation in bioprocessing will fuel the advancement of this sector and
drive the expansion of the market
- Frequent usage of
chromatography systems in the downstream process to achieve the highest
level of purity of the end product is attributive to the largest share of
the chromatography product segment in 2019
- Filters are expected to
witness an attractive growth owing to its benefits of reduction in
operating costs and an increase in adoption of membrane filters
- Purification by
chromatography is the highest revenue-generating technique segment in 2019
and is anticipated to remain so throughout the forecast period
- Antibiotic production has
demonstrated huge demand over the past few years owing to its proven
effectiveness in treating various diseases
- Moreover, the increasing
incidence of antibiotic resistance has boosted the development of new
antibiotic products at an industrial scale
- Rigorous research towards
therapeutic applications of monoclonal antibodies boosts the growth of the
antibodies production segment
- Some of the key players
operating in downstream processing market are GE Healthcare; Merck KGaA;
Sartorius Stedim Biotech S.A.; Thermo Fisher Scientific Inc.; and Danaher
Corporation
- Other prominent players
include Repligen, 3M Company, Eppendorf AG, Boehringer Ingelheim
International GmbH, Corning Corporation, Lonza Group Ltd, Dover
Corporation, Ferner PLC, and Ashai Kasei.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/downstream-processing-market/request/rs1
Downstream
Processing Market Segmentation
Grand View Research has segmented
the global downstream processing market on the basis of product, technique,
application, and region:
Downstream
Processing Product Outlook (Revenue, USD Million, 2016 - 2027)
- Chromatography Systems
- Filters
- Evaporators
- Centrifuges
- Dryers
- Others
Downstream
Processing Technique Outlook (Revenue, USD Million, 2016 - 2027)
- Cell Disruption
- Solid-liquid separation
- Filtration
- Centrifugation
- Concentration
- Evaporation
- Membrane filtration
- Purification by
Chromatography
- Formulation
Downstream
Processing Application Outlook (Revenue, USD Million, 2016 - 2027)
- Antibiotic Production
- Hormone Production
- Antibodies Production
- Enzyme Production
- Vaccine Production
Downstream
Processing Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
- UAE
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment